Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Prothrombinex-VF in peritonectomy surgery
ACTRN12612001002875Phase 4Completed
- Sponsor
- St George Hospital
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prothrombin complex in primary peritoneal cancer (PPC) (2 arms), sponsored by St George Hospital. Primary endpoints: Efficacy of Prothrombinex in achieving haemostasis compared to standard treatment and Reduction in number of blood product units transfused. Started Oct 2013; status: completed.
02
Drugs
prothrombin complex
03
Conditions
primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on ACTRN12612001002875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001002875.